In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Lion, Tripos ally to develop drug discovery platform

Executive Summary

Lion Biosciences AG and Tripos will partner to develop a combined information management platform linking bioinformatics, cheminformatics, and data analysis. For (uf)$9mm up front, Lion will purchase about 409k Series B convertible preferred Tripos shares at $22 each for a 10.8% stake. The stock is redeemable in February 2005.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
      • Genomics-Proteomics
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Includes Equity
    • Includes Contract

Related Companies

UsernamePublicRestriction

Register